DE69221711D1 - Verabreichungsvorrichtung von Wirkstoffdispersionen mit kontrollierter Freisetzung - Google Patents

Verabreichungsvorrichtung von Wirkstoffdispersionen mit kontrollierter Freisetzung

Info

Publication number
DE69221711D1
DE69221711D1 DE69221711T DE69221711T DE69221711D1 DE 69221711 D1 DE69221711 D1 DE 69221711D1 DE 69221711 T DE69221711 T DE 69221711T DE 69221711 T DE69221711 T DE 69221711T DE 69221711 D1 DE69221711 D1 DE 69221711D1
Authority
DE
Germany
Prior art keywords
delivery device
drug delivery
controlled release
hydration
release drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69221711T
Other languages
English (en)
Other versions
DE69221711T2 (de
Inventor
Gerald S Rork
James D Pipkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69221711D1 publication Critical patent/DE69221711D1/de
Application granted granted Critical
Publication of DE69221711T2 publication Critical patent/DE69221711T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
DE69221711T 1991-12-27 1992-12-22 Verabreichungsvorrichtung von Wirkstoffdispersionen mit kontrollierter Freisetzung Expired - Fee Related DE69221711T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (2)

Publication Number Publication Date
DE69221711D1 true DE69221711D1 (de) 1997-09-25
DE69221711T2 DE69221711T2 (de) 1998-03-12

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69221711T Expired - Fee Related DE69221711T2 (de) 1991-12-27 1992-12-22 Verabreichungsvorrichtung von Wirkstoffdispersionen mit kontrollierter Freisetzung

Country Status (26)

Country Link
EP (1) EP0549331B1 (de)
JP (1) JPH089534B2 (de)
KR (1) KR100281609B1 (de)
CN (1) CN1074368A (de)
AT (1) ATE157001T1 (de)
AU (1) AU660057B2 (de)
BG (1) BG61751B1 (de)
CA (1) CA2085871C (de)
CZ (1) CZ284045B6 (de)
DE (1) DE69221711T2 (de)
DK (1) DK0549331T3 (de)
ES (1) ES2106838T3 (de)
FI (1) FI109451B (de)
GR (1) GR3024885T3 (de)
HU (1) HU219594B (de)
IL (1) IL104189A (de)
LV (1) LV12082B (de)
MX (1) MX9207541A (de)
NO (1) NO310672B1 (de)
NZ (1) NZ245514A (de)
PL (1) PL171110B1 (de)
RO (1) RO112810B1 (de)
RU (1) RU2127586C1 (de)
SK (1) SK279964B6 (de)
WO (1) WO1993012765A1 (de)
YU (1) YU48762B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
EP0961611B1 (de) * 1997-01-14 2002-03-27 LTS Lohmann Therapie-Systeme AG Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
JP3573287B2 (ja) 2000-08-08 2004-10-06 第一製薬株式会社 高吸収性固形製剤
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
EP1458352A1 (de) * 2001-12-18 2004-09-22 Novo Nordisk A/S Festdosis-mikroimplantat
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
KR20050071517A (ko) * 2002-09-28 2005-07-07 맥네일-피피씨, 인코포레이티드 코어를 2개 갖는 개질된 방출성 투여 제형
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7922702B2 (en) 2004-07-02 2011-04-12 Qlt Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
JP2009532132A (ja) 2006-03-31 2009-09-10 キューエルティー プラグ デリバリー,インク. 薬物治療用鼻涙排液系インプラント
RU2010112417A (ru) 2007-09-07 2011-10-10 Клт Плаг Диливери, Инк. (Us) Обнаружение лакримальных имплантатов
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
CN103889401B (zh) 2011-08-29 2017-10-13 Qlt公司 持续释放递送活性剂以治疗青光眼和高眼压
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル 1型ヘルパーt細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
KR100281609B1 (ko) 2001-02-15
RU94031474A (ru) 1997-04-20
LV12082A (lv) 1998-07-20
SK76994A3 (en) 1995-05-10
YU48762B (en) 1999-11-22
KR940703653A (ko) 1994-12-12
IL104189A (en) 1996-10-31
RO112810B1 (ro) 1998-01-30
FI109451B (fi) 2002-08-15
NO942430D0 (no) 1994-06-27
FI943011A0 (fi) 1994-06-22
AU660057B2 (en) 1995-06-08
DK0549331T3 (da) 1997-09-15
NO310672B1 (no) 2001-08-13
DE69221711T2 (de) 1998-03-12
AU3034892A (en) 1993-08-12
CN1074368A (zh) 1993-07-21
MX9207541A (es) 1994-06-30
CZ284045B6 (cs) 1998-07-15
HU9401913D0 (en) 1994-09-28
ATE157001T1 (de) 1997-09-15
HUT70437A (en) 1995-10-30
GR3024885T3 (en) 1998-01-30
NZ245514A (en) 1994-12-22
PL171110B1 (pl) 1997-03-28
JPH089534B2 (ja) 1996-01-31
RU2127586C1 (ru) 1999-03-20
YU111292A (sh) 1995-12-04
CA2085871A1 (en) 1993-06-28
WO1993012765A1 (en) 1993-07-08
BG98805A (bg) 1995-03-31
SK279964B6 (sk) 1999-06-11
JPH05255071A (ja) 1993-10-05
CA2085871C (en) 2002-05-07
EP0549331A1 (de) 1993-06-30
FI943011A (fi) 1994-06-22
BG61751B1 (bg) 1998-05-29
IL104189A0 (en) 1993-05-13
ES2106838T3 (es) 1997-11-16
LV12082B (en) 1998-09-20
HU219594B (hu) 2001-05-28
EP0549331B1 (de) 1997-08-20
CZ157094A3 (en) 1994-12-15
NO942430L (no) 1994-06-27

Similar Documents

Publication Publication Date Title
DE69221711T2 (de) Verabreichungsvorrichtung von Wirkstoffdispersionen mit kontrollierter Freisetzung
ATE244001T1 (de) Verabreichungssystem mit gesteuerter freisetzung einer arzneistoffsuspension
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
CA2222359A1 (fr) Composition cosmetique comprenant l'association d'un polymere filmogene et d'une dispersion de cire et utilisation de ladite association
IN171312B (de)
GB9112267D0 (en) Polymeric coating
ATE205706T1 (de) Wirkstoffpflaster
DE59505047D1 (de) Versprühbare filmbildende wirkstoffabgabesysteme zur anwendung an pflanzen
NO931859D0 (no) Blanding for kontrollert frigjoering av en aktiv bestanddel
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
YU47887B (sh) Postupak za pravljenje čvrstog farmaceutskog preparata za oslobadjanje aktivne supstance
ES2061786T3 (es) Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante.
CA2206211A1 (en) A controlled release drug suspension delivery device

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee